Form 8-K - Current report:
SEC Accession No. 0001193125-25-002252
Filing Date
2025-01-06
Accepted
2025-01-06 17:26:54
Documents
15
Period of Report
2025-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d875266d8k.htm   iXBRL 8-K 25467
2 EX-10.1 d875266dex101.htm EX-10.1 9864
  Complete submission text file 0001193125-25-002252.txt   175917

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ndoi-20250106.xsd EX-101.SCH 3208
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndoi-20250106_def.xml EX-101.DEF 11749
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndoi-20250106_lab.xml EX-101.LAB 18994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndoi-20250106_pre.xml EX-101.PRE 12265
17 EXTRACTED XBRL INSTANCE DOCUMENT d875266d8k_htm.xml XML 4616
Mailing Address 1400 ATWATER DRIVE MALVERN PA 19355
Business Address 1400 ATWATER DRIVE MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 25512447
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)